Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung CancerAlexander Drilon, Vivek Subbiah, Nir Peled et al.|New England Journal of Medicine|2020Cited by 835
Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial DiseaseEhrin J. Armstrong, John R. Laird, Debbie C. Chen et al.|Journal of the American Heart Association|2014Cited by 243
PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung CancersAlexander Drilon, Kristoffer Staal Rohrberg, Geoffrey R. Oxnard et al.|Journal of Thoracic Oncology|2019Cited by 81
Gender-related variation in the clinical presentation and outcomes of critical limb ischemiaCaroline E. McCoach, John R. Laird, Ehrin J. Armstrong et al.|Vascular Medicine|2013Cited by 61
Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cellsMoiez Ali, Kris C. Wood, Min Lu et al.|Science Translational Medicine|2022Cited by 45